InvestorsHub Logo

biopharm

06/09/17 8:45 AM

#299180 RE: spankyvol #299179

I disagree. It is all about biomarkers and Peregrine has them...


From Caris..to Foundation Medicine....IBM Watson....it is about molecular profiling and getting those Sunrise biomarkers into the system that will prove the puzzle pieces of PS Targeting is required for the most optimal immune response
https://www.genomeweb.com/cancer/caris-foundation-medicine-provide-tumor-profiling-nci-targeted-therapy-study